AMVUTTRA® programs and events

Programs and Events

Learn about AMVUTTRA, a treatment for the polyneuropathy caused by hATTR amyloidosis in adults.

Find an event in your area.

Patient Educational Event
Kansas City, Missouri
February 22, 2025
11:00 AM
to 12:30 PM CT
Hear from an Alnylam Patient Education Liaison, Paul, joined by Patient Ambassador, Art, treated with AMVUTTRA, and Dr. Zubair Shah, MD, a healthcare professional experienced in the management of the polyneuropathy caused by hATTR amyloidosis.
Register
Patient Educational Event
Plano, Texas
February 22, 2025
12:00 PM
to 1:30 PM CT
Hear from an Alnylam Patient Education Liaison, Mari, joined by Patient Ambassador, Al, treated with AMVUTTRA and Deborah, his spouse and caregiver, and Dr. David Avila, MD, a healthcare professional experienced in the management of the polyneuropathy caused by hATTR amyloidosis.
Register
Patient Educational Event
Indianapolis, Indiana
February 27, 2025
6:00 PM
to 7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Teresa, joined by Patient Ambassador, Kelly, treated with AMVUTTRA, and Dr. Abdul Bikak, MD, a healthcare professional experienced in the management of the polyneuropathy caused by hATTR amyloidosis
Register
Patient Educational Event
Baltimore, Maryland
February 27, 2025
6:30 PM
to 8:00 PM ET
Hear from an Alnylam Patient Education Liaison, Jeffrey, joined by Patient Ambassador, Gary, treated with AMVUTTRA, and Dr. Olakunle Akinboboye, MD, a healthcare professional experienced in the management of the polyneuropathy caused by hATTR amyloidosis.
Register
Patient Educational Event
Paramus, New Jersey
February 28, 2025
6:00 PM
to 7:30 PM ET
Hear from an Alnylam Patient Education Liaison, Sue, joined by Patient Ambassador, Christine, treated with AMVUTTRA, and Dr. Mahsa Mehrazin, MD, a healthcare professional experienced in the management of the polyneuropathy caused by hATTR amyloidosis.
Register
Up next Find a Treatment Center

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about AMVUTTRA® (vutrisiran)?

AMVUTTRA can cause:

  • Low Vitamin A Levels

    Treatment with AMVUTTRA lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

    Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking AMVUTTRA, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of AMVUTTRA?

The most common side effects of AMVUTTRA are pain in the arms or legs, pain in the joints (arthralgia), shortness of breath (dyspnea), and low vitamin A levels.

These are not all the possible side effects of AMVUTTRA. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Indication

What is AMVUTTRA?

AMVUTTRA is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). AMVUTTRA is used in adults only.

For additional information about AMVUTTRA, please see the full Prescribing Information.

For healthcare providers
Footer Waves Left Footer Waves Right